The FCA has reported a 97.5% increase in financial promotions being amended or withdrawn in 2024 following regulator intervention, almost double compared to the previous year. The number of financial ...

Are you a print subscriber? Activate your account. By Mike Lacey - 1 hour 1 min ago By Tim Nudd - 1 hour 27 min ago By Garett Sloane - 5 hours 15 min ago By Jon Springer - 8 hours 45 min ago 8 ...

A nationwide surge in flu, COVID-19, RSV and norovirus infections is fueling concerns of a possible virus "quademic." Or is it just winter? The three respiratory viruses plus norovirus ...

Add videos to your saved list and come back to them any time.

GSK has been the dominant player in the RSV vaccine market since Arexvy first gained approval in 2023, although Pfizer has made inroads into its market share. While initial launches for both ...